Related Experiment Video
Updated: Aug 7, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
High factor-VII activity in the elderly is related to vascular disease through activation of the coagulation system
Insights
High factor-VII activity in elderly individuals is linked to increased risks of vascular disease. This condition is associated with elevated cholesterol and signs of coagulation activation, not endothelial cell injury.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Geriatrics
Background:
- High factor-VII activity is an emerging risk factor for coronary artery disease.
- The study investigates the link between high factor-VII activity, endothelial cell injury, and coagulation in the elderly.
Purpose of the Study:
- To determine if high factor-VII activity in elderly patients stems from endothelial cell injury.
- To assess if high factor-VII activity contributes to vascular disease via coagulation system activation.
Main Methods:
- Compared 27 healthy elderly men with high factor-VII activity to 22 with low activity.
- Included 36 patients with existing vascular disease (coronary artery disease, cerebral infarction).
- Measured endothelium-derived markers, coagulation inhibitors, activation markers, lipoprotein (a), and cholesterol levels.
Main Results:
- Endothelial cell injury markers did not differ between high and low factor-VII activity groups.
- High factor-VII activity group showed higher levels of coagulation inhibitors, activation markers, lipoprotein (a), and total cholesterol.
- Vascular disease patients exhibited coagulation and lipid profiles closer to the high factor-VII group.
Conclusions:
- High factor-VII activity in the elderly is not primarily caused by endothelial cell injury.
- It is associated with hyperlipidemia (including lipoprotein (a)) and in vivo coagulation activation.
- Elderly individuals with high factor-VII activity have a predisposition to vascular disease.
Background:
High factor-VII activity has recently been recognized as an independent risk factor for coronary artery disease. The aim of the present study was to determine whether high levels of factor-VII activity in elderly patients are caused by endothelial cell injury and are related to vascular disease through activation of the coagulation system.
Methods:
We studies 27 asymptomatic healthy elderly men with high factor-VII activity (155-206%) and 22 healthy elderly men with low factor-VII activity (96-122%) selected from 246 men over 60 years of age attending annual health examinations. We also studied 36 patients with vascular disease (22 with coronary artery disease and 14 with chronic cerebral infarction).
Results:
The levels of endothelium-derived markers (thrombomodulin, tissue plasminogen activator-plasminogen activator inhibitor-1 complex, active plasminogen activator inhibitor 1 and tissue factor pathway inhibitor) did not differ between the subjects with high and those with low factor-VII activity. We therefore conclude that high factor-VII activity is not primarily caused by endothelial cell injury. The high-factor-VII group had higher levels of coagulation inhibitors (protein C, antithrombin III and heparin cofactor II), coagulation activation markers (prothrombin fragment 1 + 2, D-dimer and plasmin-alpha2- plasmin-inhibitor complex), lipoprotein (a) and total cholesterol than the low-factor-VII group. The coagulation and lipid profiles of the group with vascular disease were closer to those of the high-factor-VII group than to those of the low-factor-VII group; the same was true of elevated active plasminogen activator inhibitor-1 levels.
Conclusion:
High factor-VII activity in the elderly is accompanied by hyperlipidaemia, including increased levels of lipoprotein (a), and leads to coagulation activation in vivo. Thus, elderly people with high factor-VII activity are predisposed to vascular disease.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Clot Retraction and Fibrinolysis
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management

